Investigación / Grupos de investigación

Grupo  401

Microbiología clínica y enfermedades Infecciosas

Publicaciones (1273)

  • Escribano, P; Cuéllar, LA; Alvarez-Gutiérrez, A; Muñoz, P; Guinea, J.

    Detecting Echinocandin Resistance in C. glabrata Using Commercial Methods: Are CLSI or EUCAST Breakpoints Suitable for Categorical Classification?

    MYCOSES. 2024; 67(11): [doi:10.1111/myc.70003]

  • Garcia-Hernandez, S; Higuero-Cantonero, F; Garcia, FD; Chico, AA; Aceituno, JB; Garcia, SZ; Godoy, JLA; Iglesias, JH; Perez, AEL; Garutti, I.

    Predicting Responses to Interventional Pain Management Techniques for Chronic Low Back Pain: A Single-Center Observational Study (PReTi-Back Study

    Pain Physician. 2024; 27(8):

  • Garcia-Hernandez S; Higuero-Cantonero F; de la Gala Garcia F; Alonso Chico Á; Blanco Aceituno J; Zapatero Garcia S; Aguilar Godoy JL; Hortal Iglesias J; Lopez Perez AE; Garutti I.

    Predicting Responses to Interventional Pain Management Techniques for Chronic Low Back Pain: A Single-Center Observational Study (PReTi-Back Study).

    Pain Physician. 2024; 27(8):

  • de la Villa, S; Sánchez-Martínez, C; Cercenado, E; Padilla, B; Vicente, T; Serrano, J; Urbina, L; Muñoz, P.

    Effectiveness of short treatment duration for carbapenemase-producing Enterobacterales in bloodstream-infections: A retrospective cohort study

    International Journal of Antimicrobial Agents. 2024; 64(5): Nº de citas: 3 [doi:10.1016/j.ijantimicag.2024.107318]

  • Bassy Navarro, S.; Gil Villanueva, N.; Camino-López, M.; Alonso Fernández, R.; Lázaro-Martín, B.; Hernanz-Lobo, A.; Navarro Gómez, M..

    Importance of optimizing routine immunization schedules in pediatric heart transplantation

    Vacunas. 2024; 25(4): 454-461 [doi:10.1016/j.vacun.2024.07.002]

  • Irigoyen-von-Sierakowski, A; Ocaña, A; Sanchez-Mayoral, R; Cercenado, E.

    Real-world performance of susceptibility testing for cefiderocol: insights from a prospective multicentre study on Gram-negative bacteria

    JAC-Antimicrobial Resistance. 2024; 6(5): Nº de citas: 7 [doi:10.1093/jacamr/dlae169]

  • Vallet-Regi, M; De Alarcón, A; Barrena, EG; Planell, JA; Silva, J; Bouza, E.

    New materials and complications of prostheses in humans: situation in Spain

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2024; 37(5): Nº de citas: 2 [doi:10.37201/req/039.2024]

  • Díaz-Navarro, M; Hafian, R; Pérez-Granda, MJ; Cercenado, E; Muñoz, P; Guembe, M.

    Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2024; 42(8): 435-438 Nº de citas: 1 [doi:10.1016/j.eimc.2024.02.005]

  • Alba, C; Herranz, C; Monroy, MA; Aragón, A; Jurado, R; Díaz-Regañón, D; Sánchez, C; Tolín, M; Miranda, C; Gómez-Taylor, B; Sempere, F; Alvarez-Calatayud, G; Rodríguez, JM.

    Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan-McDermid Syndrome

    Microorganisms. 2024; 12(10): Nº de citas: 1 [doi:10.3390/microorganisms12102006]

  • Fernández-Ruiz M; Castón JJ; Del Pozo JL; Carratalà J; Fortún J; Salavert M; Torre-Cisneros J; Aguado JM; Fernández Cruz A; Ventura A; Loeches B; Dueñas C; Tomás C; Navarro D; Oltra R; Resino-Foz E; García Vázquez E; Míguez E; Merino E; Braojos F; Martínez FJ; López-Medrano Pérez F; Machuca I; Cobo J; López Contreras J; Reguera JM; Ruiz Mesa JD; Tiraboschi J; Abella L; Masiá M; Del Toro López MD; Díaz López MD; Carrasco-Antón N; Merchante N; Muñoz P; Torres R; Rodríguez R; Mata-Forte T; Abril V.

    How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2024; 42(8): 442-452 Nº de citas: 5 [doi:10.1016/j.eimce.2024.07.001]

  • Escrihuela-Vidal, F; Fernández-Hidalgo, N; Muñoz, P; Villamarín, M; García, NJ; Escudero, EM; Marcos, FJM; Cuervo, G; Boix-Palop, L; Berbel, D; Carratalà, J; Miró, JM.

    Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024; 79(12): 3230-3235 Nº de citas: 1 [doi:10.1093/jac/dkae345]

  • Muñoz, P; Guembe, M; Pérez-Granda, MJ; del Pozo, JL; López-Cortés, LE; Pittiruti, M; Martín-Delgado, MC; Bouza, E.

    Vascular catheter-related infections: an endemic disease in healthcare institutions. An opinion paper of the Spanish Society of Cardiovascular Infections (SEICAV)

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2024; 37(5): Nº de citas: 2 [doi:10.37201/req/051.2024]

  • Pérez-Granda, MJ; Blanco, FG; Díaz, SA; Bautista, RJ; Velilla, JO; Calero, JR; Valls, ML; Arellano, AV; Santos, PG; Munoz, P; Guembe, M.

    The endoscopy department can alert to complications associated with peripheral venous catheters in patients admitted to a tertiary teaching hospital

    Heliyon. 2024; 10(17): [doi:10.1016/j.heliyon.2024.e35082]

  • Gómez-Zorrilla, S; Becerra-Aparicio, F; Sendra, E; Zamorano, L; Grau, I; Pintado, V; Padilla, B; Benito, N; Boix-Palop, L; Fariñas, MC; Peñaranda, M; Gamallo, MR; Martinez, JA; Morte-Romea, E; Del Pozo, JL; Montesinos, IL; Durán-Jordà, X; Ponz, R; Cotarelo, M; Cantón, R; Oliver, A; Ruiz-Garbajosa, P; Horcajada, JP.

    Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain

    Journal of Hospital Infection. 2024; 151: 173-185 Nº de citas: 8 [doi:10.1016/j.jhin.2024.05.020]

  • Buhl, MEJ; Sunnerhagen, T; Join-Lambert, O; Morris, T; Jeverica, S; Assous, MV; Toprak, NU; Alcalá-Hernandez, L; Lienhard, R; Veloo, ACM; Cruz, H; Sóki, J; Novak, A; Mazzariol, A; Wybo, I; Dumont, Y; Justesen, US.

    Antimicrobial resistance surveillance of Bacteroides fragilis isolated from blood cultures, Europe, 2022 (ReSuBacfrag)

    International Journal of Antimicrobial Agents. 2024; 64(3): Nº de citas: 13 [doi:10.1016/j.ijantimicag.2024.107241]

  • Machado, M; Fortún, J; Muñoz, P.

    Invasive aspergillosis: A comprehensive review

    MEDICINA CLINICA. 2024; 163(4): 189-198 Nº de citas: 21 [doi:10.1016/j.medcli.2024.01.045]

  • Buenestado-Serrano, S; Martínez-Lirola, M; Dippenaar, A; Sanz-Pérez, A; Garrido-Cardenas, JA; Esteban-García, AB; García-Toledo, AJ; Rodríguez-Grande, C; Herranz-Martín, M; Saleeb, SM; Muñoz, P; Warren, RM; Pérez-Lago, L; de Viedma, DG.

    Bridging the gap between molecular and genomic epidemiology in tuberculosis: inferring MIRU-VNTR patterns from genomic data

    JOURNAL OF CLINICAL MICROBIOLOGY. 2024; 62(9): [doi:10.1128/jcm.00741-24]

  • Mutschler, E; Roloff, T; Neves, A; Aamot, HV; Rodriguez-Sanchez, B; Ramirez, M; Rossen, J; Couto, N; Novais, A; Howden, BP; Brisse, S; Reuter, S; Nolte, O; Egli, A; Seth-Smith, HMB.

    Towards unified fi ed reporting of genome sequencing results in clinical microbiology

    PeerJ. 2024; 12: Nº de citas: 4 [doi:10.7717/peerj.17673]